scispace - formally typeset
N

Niraj Mistry

Researcher at University of Toronto

Publications -  27
Citations -  2935

Niraj Mistry is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 7, co-authored 21 publications receiving 2662 citations. Previous affiliations of Niraj Mistry include St. Michael's GAA, Sligo & St. Michael's Hospital.

Papers
More filters
Journal ArticleDOI

Interventions for enhancing medication adherence.

TL;DR: The research in this field needs advances, including improved design of feasible long-term interventions, objective adherence measures, and sufficient study power to detect improvements in patient-important clinical outcomes.
Journal ArticleDOI

Technology-mediated interventions for enhancing medication adherence

TL;DR: Evidence for the inconsistent effectiveness of TMI for medication adherence and clinical outcomes is provided, with a lack of high-quality studies being interpreted with caution.
Journal ArticleDOI

Text messages for influenza vaccination among pregnant women: A randomized controlled trial.

TL;DR: In this paper, the authors evaluate if text message reminders increase the likelihood of receiving the influenza vaccine among pregnant women, and they found that the vaccine acceptance was associated with being married compared to single (95% vs. 67%).
Journal ArticleDOI

Optimizing physician handover through the creation of a comprehensive minimum data set.

TL;DR: The objective of this study was to describe the process of developing a single comprehensive hospital-wide MDS, created through an analysis of current handover processes and customary information tools used to support physician handover (MDHO) at a large quaternary care pediatric academic health sciences centre.
Journal ArticleDOI

Are some children with empyema at risk for treatment failure with fibrinolytics? A multicenter cohort study.

TL;DR: Predicting which children with empyema are at risk for treatment failure with fibrinolytics remains challenging, and possible risk factors include positive blood culture, immediate admission to intensive care, and absence of complex septations on ultrasound.